Recommendation to suspend the use of Johnson’s COVID vaccine in the US

The US health authorities have recommended a temporary suspension of the coronavirus vaccine, developed by US pharma giant Johnson & Johnson, following reports of blood clots in some people.

The US Food and Drug Administration (FDA) has described the move as a “precautionary measure.”

According to the BBC, at least 600,000 people have been vaccinated against Johnson’s corona so far. Of these, only six had blood clots.

In multiple tweets on Tuesday, the FDA and the US Centers for Disease Control and Prevention (CDC) said six people in the United States had been diagnosed with severe blood clots after Johnson’s corona vaccine. We urge you to suspend the use of this ticker as an additional precaution.

However, the two organizations have commented that such negative incidents are very rare after the vaccination at the moment. They say the move is aimed at ensuring that healthcare communities are aware of the potential for such adverse events.

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments